A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia

Immune checkpoint inhibitors (ICIs) as positive modulators of immune response have revolutionized the treatment of cancer and have achieved impressive efficacy in melanoma and numerous solid tumor malignancies. These agents are being investigated in acute myeloid leukemia (AML) to further enhance re...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Dan, Wang, Mengyao, Liao, Yi, Li, Jun, Niu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562221/
https://www.ncbi.nlm.nih.gov/pubmed/31244654
http://dx.doi.org/10.3389/fphar.2019.00609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562221/
https://www.ncbi.nlm.nih.gov/pubmed/31244654
http://dx.doi.org/10.3389/fphar.2019.00609

Ejemplares similares